Spiegel, J.
Arnold, S. http://orcid.org/0000-0002-3368-1688
Salbach, H.
Gotti, E. G.
Pfeiffer, E.
Lehmkuhl, U.
Correll, C. U. http://orcid.org/0000-0002-7254-5646
Jaite, C. http://orcid.org/0000-0003-3086-3897
Article History
Received: 26 November 2019
Accepted: 1 February 2021
First Online: 7 March 2021
Compliance with ethical standards
:
: Dr. Correll has been a consultant and/or advisor to or has received honoraria from: Acadia, Alkermes, Allergan, Angelini, Axsome, Gedeon Richter, IntraCellular Therapies, Janssen/J&J, Karuna, LB Pharma, Lundbeck, MedAvante-ProPhase, MedInCell, Medscape, Merck, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Rovi, Servier, Sumitomo Dainippon, Sunovion, Supernus, Takeda, and Teva. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Lundbeck, Rovi, Supernus, and Teva. He has received grant support from Janssen and Takeda. He is also a stock option holder of LB Pharma. The other authors declared no conflicting interests.
: All the procedures performed in this study were in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethical approval was obtained through the ethics committee of the Charité – Universitätsmedizin Berlin.
: Participants and their legal guardians provided written informed consent prior to their participation.